Longevity clinics compared
Switzerland, Thailand, Japan, the United States, China. Five destinations, one word, and at least four completely different products underneath it. What actually separates them is not the view from the window — it is what each one is legally permitted to give you, and that is knowable before you book anything.
The short answer
“Longevity clinic” is a marketing category, not a clinical one. Nobody licenses the term and nobody polices it, so it sits on top of four business models that share almost nothing: the Alpine clinic, the Asian wellness resort, the American diagnostics-first programme, and the hospital-attached assessment. They differ in what is measured, who reads it, what can be done about it on site, and — the variable almost every comparison misses — which regulatory route the provider is operating on, because that decides what may lawfully be delivered to you at all.
Nothing below is a ranking. Three of these models are perfectly good purchases for the right person, and the fourth is a holiday with a blood test. What follows is the structure, so you can work out which one you are actually being sold.
Four models share one word
| Model | Organised around | What happens if something is found | Typical length |
|---|---|---|---|
| The Alpine clinic Switzerland, Austria, northern Italy | A diagnostic battery wrapped in hospitality, physiotherapy, nutrition and aesthetic medicine | Referral to a Swiss hospital or home to your own physician | One to three weeks |
| The Asian wellness resort Thailand, Bali, Vietnam | Lifestyle: sleep, food, movement, detoxification programmes, spa therapies, some diagnostics | Referral out, usually to a city hospital | Three to twenty-one nights |
| Diagnostics first United States, United Kingdom, Gulf | Advanced imaging, extended panels, biological-age reporting, continuous monitoring, usually sold on a subscription | Referral into ordinary insurance-funded care | A day, then a year of remote follow-up |
| Hospital-attached Hainan, Japan, Singapore | A screening battery run inside a licensed hospital, read by a multi-disciplinary panel | Treated in the same building, on the same records | Three to seven days |
The fourth column is where most disappointment is manufactured. A resort and a hospital can run the identical blood panel and the identical 3.0T MRI; the difference only becomes visible on the day something turns up on the scan, and by then you have chosen.
The variable that actually separates them
If you strip away the architecture, the one durable difference between longevity clinics in different countries is the legal route the provider operates on. It is the same point that decides everything about cell therapy abroad, and it generalises cleanly: a facility can only sell you what its regulator permits it to sell, and regulators differ far more than brochures do.
There are broadly three routes. A provider can work inside ordinary medical practice — consultations, imaging, laboratory tests, licensed drugs, physiotherapy. It can work inside a clinical trial, where an unproven intervention is permitted precisely because it is being measured. Or it can work on a special pathway that a particular jurisdiction has built to allow something between the two: Japan’s notification system for regenerative medicine, or China’s pilot zone. Everything else — the clinics that offer unlicensed cell products under general practice licensing, in whichever country currently tolerates it — is operating in the gap between routes, and the gap is narrowing everywhere.
Switzerland: the Alpine clinic
The Alpine model is the oldest and the most copied. A week or more in a lakeside or mountain property, an extensive diagnostic workup, a physician-led plan, and a supporting cast of physiotherapy, nutrition, dentistry and aesthetic medicine. It is good at what it does, and what it does is mostly excellent conventional medicine delivered slowly and comfortably.
What Switzerland does not offer is retail cell therapy. Cell-based medicinal products are held to a full therapeutic-products standard, which means authorisation, manufacturing controls and evidence — the same bar a new drug faces. The historical association between Swiss clinics and “fresh cell” injections of animal cells belongs to an earlier era and to a practice that was never licensed medicine and carried real anaphylactic risk. A modern Swiss longevity week is diagnostics, lifestyle medicine and aesthetics, priced at roughly $39,000 to $115,000, and it is honest about that.
Thailand: the resort model
Thailand’s best wellness properties are genuinely world-class at the thing they are actually for: a long, structured reset built on sleep, food, movement, bodywork and time. Many now attach a diagnostic layer and a visiting physician, and some market longevity programmes with cell or stem cell components.
Here the regulatory line is unusually clear and unusually ignored. The Medical Council of Thailand restricts stem cell treatment to haematopoietic stem cell transplantation for approved haematological indications, and to approved research. Anything else offered as a stem cell service sits outside that scope. That does not make the retreat itself a bad purchase — it makes the stem cell line item the part to interrogate. If you are going to Thailand for the reset, you will probably get an excellent one. If you are going for the cells, you are buying something the country’s own medical council has said should not be sold to you.
Japan: the notified-pathway model
Japan built the middle route that most countries lack. Under its 2014 Act on the Safety of Regenerative Medicine, regenerative treatments are sorted into risk classes; a provider submits a treatment plan to a certified committee and notifies the health ministry, after which the treatment may be provided outside a clinical trial. It is a real legal pathway with real documentation behind it, and it is why a great deal of autologous cell work is available to international patients in Japan.
The caveat is the one most providers skip. Plan review and notification are a safety-process mechanism. They confirm that a competent committee looked at the protocol, the facility and the manufacturing. They do not certify that the treatment works, and a notified therapy has not thereby been shown to be effective. That is a defensible system, and it is also not the same thing as a licensed indication.
The United States: diagnostics first
The American model solved the regulatory problem by not going near it. Cell products that are more than minimally manipulated are biological drugs requiring an investigational or licensing application, and the period of enforcement discretion around that ended in 2021. So the American longevity clinic sells what it can lawfully sell in volume: advanced imaging, extended laboratory panels, continuous glucose monitoring, cardiovascular and cancer-risk workups, biological-age reporting, and a physician relationship on a subscription.
The strength is data density and follow-through — nobody does the twelve-month cadence better. The weakness is that the model is downstream-poor: when something is found, you are handed back into ordinary insurance-funded care and the clinic’s involvement effectively ends. It is also the model most exposed to the incidental-finding problem, where broad imaging of healthy people produces findings that lead to further scans, biopsies and anxiety without a demonstrated mortality benefit.
China: a hospital inside a pilot zone
The retreat described on this site is the fourth model, and the thing that makes it different is not the island. It is that the screening runs inside a licensed tertiary hospital in the Boao Lecheng pilot zone, so the referral problem does not exist: the panel that reads your scans works in the building where you would be treated, and what happens across the four days is designed around that.
The zone is also the reason the cell-therapy answer here is narrow rather than expansive. Licensed cell and gene therapy is delivered for therapeutic purpose only — it proceeds where the assessment finds a treatable condition, or where you arrive holding a diagnosis or prescription from your own physician. It is not sold as an anti-ageing purchase. The rules that produce that answer, including State Council Order No. 818, are set out in full in is stem cell therapy legal in China? rather than re-argued here. Separately, the hospitals run a set of non-cell protocols — plasma exchange, mitochondrial and NAD+ courses, whole-body hyperthermia — which carry no disease-indication requirement, and correspondingly none of the scaffolding that requirement brings with it.
On price the comparison is unusually legible for once: the four-day retreat is offered from about $2,700 all-in against the Alpine $39,000 to $115,000, and what a longevity program in China costs sets out where that gap comes from. It is the cost base and the hospital setting, not a discount and not older equipment.
The comparison, in one table
| Switzerland | Thailand | Japan | United States | Hainan, China | |
|---|---|---|---|---|---|
| Route | Ordinary practice; full medicinal-product standard for cell products | Ordinary practice; stem cells restricted to approved transplantation and research | Notification and certified-committee plan review | Ordinary practice; cell products are drugs | Pilot-zone licensing against filed disease indications |
| Cell therapy as a wellness purchase | No | No | Possible under notification, safety-reviewed not efficacy-approved | No | No — therapeutic purpose only |
| Treated on site if something is found | Referral | Referral | Varies by provider | Referral | Yes, same hospital |
| Published price | Roughly $39,000–115,000 a week | Varies; rarely all-in | Rarely published | Subscription, usually annual | Retreat from about $2,700; treatment programmes quoted in writing |
| Best for | A thorough, comfortable workup with unusually good aftercare on site | A genuine behavioural reset | A specific autologous cell treatment with paperwork behind it | Data density and a twelve-month cadence | A hospital-grade baseline where findings are acted on immediately |
What none of them has shown
No longevity clinic in any country has demonstrated that it extends life, because no trial capable of showing it has been run. There is no randomised controlled study of a longevity programme with a lifespan or all-cause-mortality endpoint. What the industry reports instead are surrogate endpoints — epigenetic age clocks, biomarker panels, VO₂ and body-composition changes — and a surrogate describes a state rather than proving an outcome. Epigenetic clocks in particular correlate with mortality across populations; that is not the same as being validated as a target that, when moved by an intervention, changes how long one person lives.
This is not a reason to avoid the category. It is a reason to buy the parts that stand on their own evidence: finding a treatable thing early, establishing a baseline you can measure against in a year, and leaving with a plan specific enough to follow. Those are real, and they are what an honest programme in any of these countries is actually selling. What a medical wellness retreat includes sets out the version of that on this island.
Eight questions that work in any country
- Which legal route are you operating on? Ordinary practice, a clinical trial, or a named special pathway. A provider who cannot say is not a provider.
- Exactly what is measured? Ask for the marker list and the imaging list in writing. “Comprehensive assessment” is not an answer.
- Who reads the results, and how many of them? One generalist reading a hundred data points is a different product from a multi-disciplinary panel.
- What happens on site if you find something? Ask them to describe the referral, by name and by building.
- If a cell or biologic is offered: where is it manufactured, and against what release criteria? Viability, identity, sterility, endotoxin. No release testing, no product.
- What is the published evidence for the specific thing you are selling me? Not for the field. For the protocol, at the dose, in people like me.
- What is the total price, and what is invoiced separately? The gap between the headline and the invoice is where the category earns its reputation.
- What does follow-up consist of, and who does it? A report emailed after you land is not follow-up.
If the answers to one and five are vague in any country — including this one — that is the signal, and it is worth more than the brochure.
Frequently asked
What is a longevity clinic?
A longevity clinic is a facility that sells a structured attempt to measure and act on how you are ageing, rather than to treat a complaint you arrived with. In practice the name covers at least four unrelated products: the Alpine clinic, which pairs a diagnostic battery with hospitality and aesthetic medicine; the Asian wellness resort, which is a lifestyle programme with a medical veneer; the American diagnostics-first programme, which sells advanced imaging and panels on a subscription; and the hospital-attached programme, where the assessment runs inside a licensed hospital and anything found is treated there. The word tells you nothing about which one you are buying. The regulatory route the provider operates on tells you almost everything.
Which country is best for a longevity clinic?
The honest answer is that the country is the wrong first variable, the same way it is the wrong first variable for cell therapy. What differs between countries is the legal route a provider may operate on, and that decides what can lawfully be delivered to you. Switzerland and the United States both hold cell-based products to a full medicinal-product standard, so what is sold there is diagnostics, lifestyle medicine and aesthetics. Japan has a notification route that permits some cell treatments outside a trial. Thailand restricts stem cell treatment to approved haematological transplantation and to research. China permits licensed cell therapy inside the Boao Lecheng pilot zone against filed disease indications only. Decide what you actually want delivered, then ask which route permits it.
How much does a longevity clinic cost?
Published Alpine longevity programmes sit at roughly $39,000 to $115,000 for a week. The four-day retreat described on this site is offered from about $2,700 all-in, and that figure covers the screening battery, the specialist panel that reads it, the villa, the meals, the transfers and twelve months of follow-up. Licensed treatment programmes are a separate matter and are never sold from a menu: each is priced by the hospital that would deliver it and confirmed in writing before you commit. Beyond those two published figures, be sceptical of any comparison table of clinic prices you find online, including ours — the packages are not comparable line by line, and a headline number usually excludes the thing you actually came for.
Can you get stem cell therapy at a longevity clinic?
Sometimes, and the conditions matter more than the answer. In most Western jurisdictions a cell product that is more than minimally manipulated is a medicinal product and cannot be sold as a wellness service at all. In Japan a treatment plan can be reviewed by a certified committee and notified to the ministry, which permits provision outside a clinical trial — a safety-process approval, not an efficacy one. In China, licensed cell therapy in the pilot zone is delivered for therapeutic purpose only: it proceeds where the assessment finds a treatable condition, or where you arrive holding a diagnosis or prescription from your own physician. It is not available as an anti-ageing purchase, and a provider in any country offering it as one is telling you which rules they are not following.
Is a longevity clinic in Asia as good as a Swiss one?
On the measurable parts, the gap is much smaller than the price gap suggests. The scanners and the assays are the same generation; a 3.0T MRI is a 3.0T MRI. What differs is the cost base underneath, the hospitality, and — the part worth actually comparing — what sits behind the assessment when something is found. A resort has to refer you out. A hospital-attached programme treats you in the same building, under the same records. If nothing is found, you have bought a very good baseline either way, and the deciding factor is what the week costs and how well you sleep in the bed.
Do longevity clinics actually extend life?
No clinic of any model has shown that it does, because no such trial exists. There is no randomised controlled trial of a longevity programme with a lifespan or all-cause-mortality endpoint in any country, and the measures the industry reports instead — epigenetic age clocks, biomarker panels, body composition — are surrogate endpoints. They describe a state; they have not been validated as endpoints that, when moved by an intervention, predict how long an individual lives. What a good programme can defensibly claim is earlier detection, a correct baseline, and a plan you will actually follow. Anyone claiming more than that is ahead of the evidence, at any latitude and at any price.
What is the difference between a longevity clinic and a wellness retreat?
A wellness retreat is organised around how you feel and behave: sleep, food, movement, stress, recovery. A longevity clinic is organised around what can be measured and what the measurements imply. The confusion is commercial rather than conceptual — the two words have been used interchangeably in marketing for a decade, and plenty of places sell one while naming the other. The test is simple: ask for the marker list and the imaging list, and ask who reads them. A retreat that cannot produce either is a holiday, which is a perfectly good thing to buy as long as you know you are buying it.
Write to us →Tell us where you’re starting from — a care manager replies within one working day.Or download the Retreat Dossier (PDF) → — itinerary, inclusions, programs, practicalities.